Skip to main content
Clinical Trials/IRCT2013111815452N1
IRCT2013111815452N1CompletedPhase 1

Effect of dietary Fenugreek seed powder on serum lipid profiles in patients with hyperlipidemia.

Qazvin University of Medical Sciences0 sites40 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • The inclusion criteria:
  • up to 18 years and less than 65 years old; an experiment with one of the following factors related to lipid
  • LDL> 135 mg / dl; HDL <40 mg / dl; Chol> 200 mg / dl; TG> 150 mg / dl.
  • The exclusion criteria
  • having underlying diseases such as diabetes, IHD, hypertension, metabolic syndrome, peripheral vascular disease, coronary artery disease and ...; LDL more than 190 in patients that need of medical treatment (for healthy people or with one risk factor); LDL = 160 in patient that need drug treatment (for those with two or more risk factors).
  • Risk Factors: 1 - Smoking 2 - hypertension 3 - low HDL level (less than 40) 4 - history of coronary artery disease at an early age in the household (less than 55 years in males and in females under age 65years old) 5 - Age above 65 years. important point: diabetes mellitus, peripheral vascular disease and coronary artery disease are considered equivalent whit CAD. (CAD equivalent)

Exclusion Criteria

  • Not provided

Investigators

Similar Trials